Mindfulness App Training for Rumination in Adolescents
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a mindfulness app can reduce rumination—overthinking bothersome issues—among teens, potentially improving symptoms of depression and anxiety. Participants will use the Mindfulness (Headspace) App to practice mindfulness and undergo brain scans to observe changes resulting from app use. Teens who frequently experience negative thoughts and have a smartphone might be a good fit for this study. As an unphased trial, this study offers a unique opportunity for teens to contribute to understanding how mindfulness can enhance mental health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on psychotropic medication, you must be on a stable dose for at least 2 months before joining.
What prior data suggests that this mindfulness app is safe for adolescents?
Research has shown that mindfulness apps, such as Headspace, are generally safe and easy to use. Studies have found that these apps can help reduce repetitive negative thinking in teenagers, particularly those who often dwell on negative thoughts. One study found that students using mindfulness apps felt less stressed and were likely to continue using them.
Mindfulness meditation, a main feature of these apps, has been linked to improvements in depression and anxiety. Users of similar apps have reported feeling less stressed and in a better mood. No major safety issues have emerged in these studies, suggesting that mindfulness apps are a safe choice for teens wanting to manage negative thinking and improve their mental health.12345Why are researchers excited about this trial?
Researchers are excited about the Mindfulness App Training for rumination in adolescents because it offers a unique, non-invasive approach to managing repetitive negative thinking. Unlike traditional therapies, which might involve medication or face-to-face counseling, this treatment leverages the Headspace app to deliver mindfulness training directly to users through their smartphones. This method is particularly appealing as it provides an accessible, flexible, and cost-effective solution that can be integrated easily into daily life, potentially increasing adherence and engagement among teens.
What evidence suggests that this trial's treatments could be effective for reducing rumination in adolescents?
Research has shown that mindfulness meditation can help reduce rumination, which involves repetitive negative thoughts. In this trial, some participants will use the Headspace mindfulness app. Studies have demonstrated that this app leads to greater reductions in negative thoughts compared to those who do not use it. In one study, many teenagers completed their mindfulness exercises and noticed improvements. Another study showed that using a mindfulness app helped reduce negative thinking in teenagers who often ruminate. These findings suggest that the Headspace app could be a helpful tool for young people to manage rumination and possibly improve symptoms of depression and anxiety.12678
Are You a Good Fit for This Trial?
Adolescents aged 13-18, who are right-handed and fluent in English, can join this trial. They must have a personal smartphone and be on a stable dose of any psychotropic medication for at least two months. Those with certain psychiatric disorders, history of severe head trauma or substance abuse, or conditions that preclude fMRI scanning cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to an app-delivered mindfulness course or a control condition, with pre- and post-intervention fMRI scans and cognitive tasks to assess attentional control and mindfulness skills.
Follow-up
Participants are monitored for changes in rumination and mindfulness skills via smartphone-based ecological momentary assessment (EMA).
What Are the Treatments Tested in This Trial?
Interventions
- Active Control Condition ("Recharge" condition delivered in Headspace app)
- Mindfulness (Headspace) App
- Psychoeducational Active Control Condition
Mindfulness (Headspace) App is already approved in United States, European Union for the following indications:
- Anxiety
- Depression
- Stress Management
- Anxiety
- Depression
- Stress Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor
Cambridge Health Alliance
Collaborator
Lawrence University
Collaborator